Clinical Trials Logo

Smoking clinical trials

View clinical trials related to Smoking.

Filter by:

NCT ID: NCT02724462 Completed - Smoking Clinical Trials

Trial of An Innovative Smartphone Intervention for Smoking Cessation

Start date: May 27, 2017
Phase: N/A
Study type: Interventional

The goal of this study is to determine whether the novel smartphone app (SmartQuit) provides higher quit rates than the current standard smoking cessation app.

NCT ID: NCT02718872 Completed - Smoking Cessation Clinical Trials

Tobacco Cessation Training Program in Spanish-speaking Countries

FRUITFUL
Start date: January 2015
Phase: N/A
Study type: Interventional

This project is responsive to the identified gap of lack of tobacco cessation training programs in Latin American & Caribbean countries. Currently, smoking rates in the Latin American and Caribbean region are high, and previous surveys show that health professionals do not have enough skills to help smokers to quit. In consequence, in absence of trained health professionals, many smokers who visit health care services are under-treated. The Fruitful Project aims to adapt an original on-line course developed in Spain to the reality of the three Latin American countries (Bolivia, Guatemala and Paraguay) and disseminate evidence-based tobacco cessation interventions among health care professionals.

NCT ID: NCT02713594 Completed - Smoking Cessation Clinical Trials

Wisconsin Tobacco Quit Line Medicaid Incentive Evaluation

Start date: April 2013
Phase: N/A
Study type: Interventional

The study is designed to test the hypotheses that financial incentives can increase both participation in smoking cessation treatment and resulting cessation rates, when they are offered to BadgerCare Plus (Medicaid) smokers as part of their health care.

NCT ID: NCT02701686 Completed - Smoking Clinical Trials

A Comparison of the Effectiveness of Two Approaches in Achieving Smoking Abstinence

Start date: June 2014
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of negotiating self determination to reduce cigarette consumption. A single-blinded multi-centre randomized controlled is employed.

NCT ID: NCT02681510 Completed - Smoking Clinical Trials

UW-CTRI Triple Medication Smoking Cessation Study

Start date: February 2016
Phase: Phase 4
Study type: Interventional

This study will focus on enhancing future smoking cessation treatment effectiveness by piloting a potentially more powerful combination of three FDA-approved pharmacotherapies: varenicline plus combination of two types of nicotine replacement therapy (NRT) treatment (nicotine lozenge and nicotine patch). Data from this pilot study will help inform the design of future studies that would use this combination treatment as a cessation tool within the chronic care arsenal of treatments.

NCT ID: NCT02664012 Completed - Smoking Clinical Trials

Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Menthol Electronic Cigarettes vs Combustible Menthol Cigarettes and Nicotine Gum

Start date: January 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to measure plasma nicotine uptake parameters, physiological measures, and subjective effect measures in smokers during and following a single ad libitum use of three menthol electronic cigarettes versus combustible menthol cigarettes and nicotine gum.

NCT ID: NCT02663882 Completed - Smoking Clinical Trials

Self-Control and Adult Cigarette Smokers

Start date: April 2016
Phase: N/A
Study type: Interventional

The purpose of this study is to learn more about self-control and adults who smoke cigarettes. It has been suggested that people can improve self-control by practicing tasks that require the use of self-control (such as delaying cigarettes or sitting up as straight as possible). The goal of this study is to learn about whether scores on self-control and other measures will change after one week of practicing self-control tasks at home. We believe that adults who smoke cigarettes will show better self-control after practicing tasks for a week.

NCT ID: NCT02660957 Completed - Smoking Clinical Trials

Smoking Cessation Among People Attending A&E

Start date: July 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of using a brief, self-determination intervention on smoking cessation (immediate or progressive) for people attending AEDs.

NCT ID: NCT02651233 Completed - Physical Activity Clinical Trials

Factors That Influence Adipose Derived Regenerative Cells' Yield and Viability

Start date: March 2014
Phase: N/A
Study type: Observational

Human adipose tissue has been shown to contain a group of cells that possess extensive proliferative capacity and the ability to differentiate into multiple cell lineages. Cells isolated from the fatty portion are termed processed lipoaspirate cells that contain adipose-derived regenerative cells (ADRCs). ADRCs are most conveniently extracted from tissue during an elective cosmetic liposuction procedure but may also be obtained from resected adipose tissue. This study is aimed to verify if there are differences between the number and viability of cells obtained from patients with different age, sex, Body Mass Index (BMI), smoking and physical activity, within the different amount of processed fat.

NCT ID: NCT02649556 Completed - Smoking Clinical Trials

A 26-week Extension of the ZRHR-ERS-09-US Study Evaluating Biological and Functional Changes in Healthy Smokers After Switching to THS 2.2

Start date: September 30, 2015
Phase: N/A
Study type: Interventional

The objective of the ZRHR-ERS-09-EXT-US study is to further assess the effect of the Tobacco Heating System 2.2 (THS 2.2), a candidate Modified Risk Tobacco Product, compared to conventional cigarettes (CC) on the components of the "smokers' health profile" for a prolonged period of 26 weeks, providing additional information to the results of the original study ZRHR-ERS-09-US of 26-week exposure (NCT02396381). In total, the ZRHR-ERS-09-EXT-US study will extend the exposure period to 52 weeks.